Filing Flows › Escalon Medical (ESMC) › Q4 FY25
Escalon Medical (ESMC) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Sep 29, 2025
Escalon Medical (ESMC) reported revenue of $2.6M for the fourth quarter fiscal 2025 (Q4 FY25), -26% from a year earlier and -26% from the quarter before. Operating margin was -14.5%, net loss $380K (14.8% of revenue).
Escalon Medical, Q4 FY25: revenue $2.6M (-26% year over year), operating margin -14.5%, net loss $380K, operating cash flow $16K. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | -26% | -26% |
| Operating profit | −$372K | -235% | — |
| Net earnings | −$380K | -240% | — |
| Operating cash flow | $16K | -49% | — |
| Free cash flow | $12K | -61% | — |
What changed
Revenue was $2.6M in Q4 FY25, down 26% year over year and down 26% from the previous quarter. Product was the largest line at 95% of revenue.
Operating costs exceeded revenue by $372K, an operating margin of -14.5%. Total costs fell 12% while revenue fell 26%. The fastest-growing cost line was Research & development (+69%). The quarter ended with a net loss of $380K, after a profit of $271K the previous quarter.
Operating cash flow was $16K. Non-cash charges added back $9K of depreciation and amortization. Working capital and other items added $387K. Capital expenditures of $4K left free cash flow of $12K.
Questions
What was Escalon Medical's revenue in the fourth quarter fiscal 2025?
Escalon Medical (ESMC) reported revenue of $2.6M for the fourth quarter fiscal 2025 (Q4 FY25), -26% from a year earlier and -26% from the quarter before.
Was Escalon Medical profitable in the fourth quarter fiscal 2025?
Operating loss was $372K (-14.5% of revenue) and net loss $380K.
Source: Escalon Medical 10-K on SEC EDGAR.